Question

You are part of a team of doctors doing a Phase 2 study of teixobactin on humans. Assuming protocol had not changed since the mice study, how are you administering the drug?
a) through a nasal spray
b) rectally
c) orally
d) by injection

Answer 1

Answer: Teixobactin is a drug for the treatment of Tuberculosis, currently under preclinical studies

Explanation:

Teixobactin:- It is a secondary metabolite obtained from some species of bacteria, used as an anti- infective agent, especially for the treatment of Tuberculosis. Currently this drug is under preclinical study. This belongs to a new class of antibiotics

Mechanism of Action:- This drug act as a cell wall inhibitor

This drug is usually given by injection, according to the reports of development of identified for preclinical development in tuberculosis in USA